Abstract
Herlitz disease (H-JEB), the lethal form of junctional epidermolysis bullosa, is a rare genodermatosis presenting from birth with widespread erosions and blistering of skin and mucosae because of tissue cleavage within the epidermal basement membrane. Mutations in any of the three genes encoding the α3, β3 and γ2 chains of laminin-5 underlie this recessively inherited disorder. Here, we report the molecular basis and clinical course of H-JEB in 12 patients. Two novel nonsense mutations in the gene LAMA3 (E281X and K1299X) and a novel frame-shift mutation in the gene LAMB3 (1628insG) leading to a premature termination codon were identified by DNA sequencing and confirmed by restriction fragment length polymorphism analysis. In the four patients affected, neither the resulting truncated polypeptide chains nor assembled laminin-5 protein were detectable by immunofluorescence. Three patients were found to be heterozygous for the known hotspot mutation R635X and the recurrent mutations Q373X or 29insC in the gene LAMB3, whereas five others were homozygous for R635X. Significant variations in the disease progression and survival times between 1 and 30 months in this group of H-JEB patients emphasised the impact of modifying factors and the importance of immunostaining or mRNA assessment as parallel diagnostic methods. Interestingly, the only patients who survived for longer than 6 months were four females carrying the mutation R635X homozygously. In one of them, the clinical course may have been improved by treatment with artificial skin equivalents. These data may stimulate further investigation of genotype–phenotype correlations and facilitate mutation analysis and genetic counselling of affected families.
Similar content being viewed by others
References
Airenne T, Haakana H, Sainio K, Kallunki T, Kallunki P, Sariola H, Tryggvason K (1996) Structure of the human laminin gamma 2 chain gene (LAMC2): alternative splicing with different tissue distribution of two transcripts. Genomics 32:54–64
Aumailley M, Rousselle P (1999) Laminins of the dermo-epidermal junction. Matrix Biol 18:19–28
Baudoin C, Miquel C, Blanchet-Bardon C, Gambini C, Meneguzzi G, Ortonne JP (1994) Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. J Clin Invest 93:862–869
Chavanas S, Gache Y, Vailly J, Kanitakis J, Pulkkinen L, Uitto J, Ortonne J, Meneguzzi G (1999) Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. Hum Mol Genet 8:2097–2105
Christiano AM, Amano S, Eichenfield LF, Burgeson RE, Uitto J (1997) Premature termination codon mutations in the type VII collagen gene in recessive dystrophic epidermolysis bullosa result in nonsense-mediated mRNA decay and absence of functional protein. J Invest Dermatol 109:390–394
Colognato H, Yurchenco PD (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213–234
Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151–155
Cserhalmi-Friedman PB, Anyane-Yeboa K, Christiano AM (2002) Paternal germline mosaicism in Herlitz junctional epidermolysis bullosa. Exp Dermatol 11:468–470
Dunnen JT den, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124
Eady RA (2001) Epidermolysis bullosa: scientific advances and therapeutic challenges. J Dermatol 28:638–640
Fine JD, Bauer EA, McGuire J, Moshell A (1999) Epidermolysis bullosa. Clinical, epidemiologic and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Johns Hopkins University Press, Baltimore
Fine JD, Eady RA, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A, Heagerty A, Hintner H, Jonkman MF, McGrath J, McGuire J, Moshell A, Shimizu H, Tadini G, Uitto J (2000) Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 42:1051–1066
Fleischmajer R, Kuroda K, Utani A, Douglas MacDonald E, Perlish JS, Arikawa-Hirasawa E, Sekiguchi K, Sanzen N, Timpl R, Yamada Y (2000) Differential expression of laminin alpha chains during proliferative and differentiation stages in a model for skin morphogenesis. Matrix Biol 19:637–647
Gache Y, Allegra M, Bodemer C, Pisani-Spadafora A, Prost Y de, Ortonne JP, Meneguzzi G (2001) Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum Mol Genet 10:2453–2461
Goldfinger LE, Jiang L, Hopkinson SB, Stack MS, Jones JC (2000) Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5. J Biol Chem 275:34887–34893
Hentze MW, Kulozik AE (1999) A perfect message: RNA surveillance and nonsensemediated decay. Cell 96:307–310
Hirosaki T, Mizushima H, Tsubota Y, Moriyama K, Miyazaki K (2000) Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion and migration by laminin-5. J Biol Chem 275:22495–22502
Jiang QJ, Izakovic J, Zenker M, Fartasch M, Meneguzzi G, Rascher W, Schneider H (2002) Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents. J Pediatr 141:553–559
Kariya Y, Tsubota Y, Hirosaki T, Mizushima H, Puzon-McLaughlin W, Takada Y, Miyazaki K (2003) Differential regulation of cellular adhesion and migration by recombinant laminin-5 forms with partial deletion or mutation within the G3 domain of alpha3 chain. J Cell Biochem 88:506–520
Kivirikko S, McGrath JA, Pulkkinen L, Uitto J, Christiano AM (1996) Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. Hum Mol Genet 5:231–237
Klausegger A, Pulkkinen L, Pohla-Gubo G, Dallinger G, Puttinger R, Uitto J, Hintner H, Bauer JW (2001) Is screening of the candidate gene necessary in unrelated partners of members of families with Herlitz junctional epidermolysis bullosa? J Invest Dermatol 116:474–475
Kopp J, Stachel KD, Holter W, Kandler M, Campean V, Hertzberg H, Carbon R, Horch RE, Rascher W, Schneider H (2004) Haematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease. Transplantation (in press)
Kuster JE, Guarnieri MH, Ault JG, Flaherty L, Swiatek PJ (1997) IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mamm Genome 8:673–681
Lin AN (1996) Management of patients with epidermolysis bullosa. Dermatol Clin 14:381–387
Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE (1992) The dermal–epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119:695–703
Masunaga T, Shimizu H, Ishiko A, Tomita Y, Aberdam D, Ortonne JP, Nishikawa T (1996) Localization of laminin-5 in the epidermal basement membrane. J Histochem Cytochem 44:1223–1230
McGrath JA, Ashton GH, Mellerio JE, Salas-Alanis JC, Swensson O, McMillan JR, Eady RA (1999) Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. J Invest Dermatol 113:314–321
McMillan JR, McGrath JA, Pulkkinen L, Kon A, Burgeson RE, Ortonne JP, Meneguzzi G, Uitto J, Eady RA (1997) Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. Br J Dermatol 136:817–822
McMillan JR, McGrath JA, Tidman MJ, Eady RA (1998) Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa. J Invest Dermatol 110:132–137
Meng X, Klement JF, Leperi DA, Birk DE, Sasaki T, Timpl R, Uitto J, Pulkkinen L (2003) Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa. J Invest Dermatol 121:720–731
Morisaki H, Morisaki T, Newby LK, Holmes EW (1993) Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest 91:2275–2280
Nakano A, Pfendner E, Hashimoto I, Uitto J (2000) Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. J Invest Dermatol 115:493–498
Nakano A, Chao SC, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfendner E, Uitto J (2002a) Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes. Hum Genet 110:41–51
Nakano A, Lestringant GG, Paperna T, Bergman R, Gershoni R, Frossard P, Kanaan M, Meneguzzi G, Richard G, Pfendner E, Uitto J, Pulkkinen L, Sprecher E (2002b) Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families. J Am Acad Dermatol 46:510–516
Nguyen BP, Ryan MC, Gil SG, Carter WG (2000) Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol 12:554–562
Nielsen PK, Gho YS, Hoffman MP, Watanabe H, Makino M, Nomizu M, Yamada Y (2000) Identification of a major heparin and cell binding site in the LG4 module of the laminin alpha 5 chain. J Biol Chem 275:14517–14523
Peters BP, Hartle RJ, Krzesicki RF, Kroll TG, Perini F, Balun JE, Goldstein IJ, Ruddon RW (1985) The biosynthesis, processing, and secretion of laminin by human choriocarcinoma cells. J Biol Chem 260:14732–14742
Pulkkinen L, Uitto J (1999) Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol 18:29–42
Pulkkinen L, Gerecke DR, Christiano AM, Wagman DW, Burgeson RE, Uitto J (1995a) Cloning of the beta 3 chain gene (LAMB3) of human laminin 5, a candidate gene in junctional epidermolysis bullosa. Genomics 25:192–198
Pulkkinen L, McGrath JA, Christiano AM, Uitto J (1995b) Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3). Hum Mutat 6:77–84
Pulkkinen L, Meneguzzi G, McGrath JA, Xu Y, Blanchet-Bardon C, Ortonne JP, Christiano AM, Uitto J (1997) Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy. J Invest Dermatol 109:232–237
Pulkkinen L, Jonkman MF, McGrath JA, Kuijpers A, Paller AS, Uitto J (1998) LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest 78:859–867
Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K (1995) Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55:4132–4139
Ruiz-Echevarria MJ, Gonzalez CI, Peltz SW (1998) Identifying the right stop: determining how the surveillance complex recognizes and degrades an aberrant mRNA. EMBO J 17:575–589
Ryan MC, Tizard R, VanDevanter DR, Carter WG (1994) Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 269:22779–22787
Ryan MC, Lee K, Miyashita Y, Carter WG (1999) Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145:1309–1323
Scaturro M, Posteraro P, Mastrogiacomo A, Zaccaria ML, De Luca N, Mazzanti C, Zambruno G, Castiglia D (2003) A missense mutation (G1506E) in the adhesion G domain of laminin-5 causes mild junctional epidermolysis bullosa. Biochem Biophys Res Commun 309:96–103
Spirito F, Chavanas S, Prost-Squarcioni C, Pulkkinen L, Fraitag S, Bodemer C, Ortonne JP, Meneguzzi G (2001) Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation. J Biol Chem 276:18828–18835
Tsubota Y, Mizushima H, Hirosaki T, Higashi S, Yasumitsu H, Miyazaki K (2000) Isolation and activity of proteolytic fragment of laminin-5 alpha3 chain. Biochem Biophys Res Commun 278:614–620
Utani A, Nomizu M, Timpl R, Roller PP, Yamada Y (1994) Laminin chain assembly. Specific sequences at the C terminus of the long arm are required for the formation of specific double- and triple-stranded coiled-coil structures. J Biol Chem 269:19167–19175
Acknowledgements
We thank A. Spadafora and E. Röß-Zimmermann for technical assistance. This work was supported by a grant from the IEB-DEBRA, Germany, and by grant SCHN 569/3-1 from the German Research Foundation (both to H.S.) and by the Epidermolyse Bullose Association d’Entraide, by the Programme Hospitalier de Recherche Clinique from the French Ministry of Health and by AFM-Telethon Italia (to G.M.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mühle, C., Jiang, QJ., Charlesworth, A. et al. Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease. Hum Genet 116, 33–42 (2005). https://doi.org/10.1007/s00439-004-1210-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-004-1210-y